A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors-Reference-Cited by-同舟云学术

A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

Published:2008-01-03 Issue:4 Volume:62 Page:727-733
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Schelman William,Morgan-Meadows Sherry,Bailey Howard,Holen Kyle,Thomas James P.,Eickhoff Jens,Brandon Heidi,Oliver Kate,Alberti Dona,Wilding George

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-007-0656-8.pdf

Reference38 articles.

1. Jordan MA, Thrower D, Wilson L (1991) Mechanism of inhibition of cell proliferation by vinca alkaloids. Cancer Res 51:2212–2222

2. Jordan MA, Toso RJ, Thrower D et al (1993) Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci USA 90:9552–9556

3. Ling V (1992) Charles F. Kettering prize: P-glycoprotein and resistance to anticancer drugs. Cancer 69:2603–2609

4. Kowalski RJ, Giannakakou P, Hamel E (1997) Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol). J Biol Chem 272:2534–2541

5. Bollag DM, McQueney PA, Zhu J et al (1995) Epothilones, a new class on microtubule-stabilizing agents with a Taxol-like mechanism of action. Cancer Res 55:2325–2333

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-mitotic agents: Are they emerging molecules for cancer treatment?;Pharmacology & Therapeutics;2017-05

2. From Bacteria to Antineoplastic: Epothilones A Successful History;Anti-Cancer Agents in Medicinal Chemistry;2013-07-01

3. Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?;Expert Review of Anticancer Therapy;2013-01

4. Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer;Cancer Treatment Reviews;2012-04

5. Epothilones in the treatment of ovarian cancer;Future Oncology;2011-04